Name: Latest research reports of Vijaya Diagnostic Centre Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Vijaya Diagnostic Centre Ltd.
Rating: 3
Author: ICICI Securities Limited

Vijaya Diagnostic Centre Ltd.

NSE: VIJAYA | BSE: 543350 | ISIN: INE043W01024 | Industry: Healthcare Services
| Expensive Star

1025.3500 -28.20 (-2.68%)

NSE Mar 21, 2025 15:31 PM

65.30% Gain from 52W Low

Volume: 3.0M

Vijaya Diagnostic Centre Ltd.

07 Aug 2024

1025.35

-2.68%

PH relieves pain in margin of base business

Hold: Vijaya Diagnostic Centre Ltd.

Recommendation Target

ICICI Securities Limited

Vijaya Diagnostic Centre’s (Vijaya) Q1FY25 performance was ahead of our expectations. Base business grew at 19.6%driven by 16.6% YoY rise in patient footfall and 19.8% YoY jump in number of tests while EBITDA grew 17% YoY.

Number of FII/FPI investors increased from 138 to 155 in Dec 2024 qtr.